期刊文献+

三乙烯四胺基淀粉的合成及抗癌活性

Synthesis of triethylenetetramine-starch and its antitumor effects
暂未订购
导出
摘要 目的:设计合成高分子基多胺抗癌药物(三乙烯四胺基淀粉,CTS),研究其对人端粒DNA d[G3(T2AG3)3]的作用机制和细胞毒性,提供高分子靶向抗癌药物的另一种开发思路。方法:以三乙烯四胺为出发点,通过环氧氯丙烷为桥梁连接到廉价淀粉上获得化合物CTS,通过各种光谱手段对CTS进行表征,运用圆二色CD光谱研究其与人端粒DNA的相互作用机制,采用CCK-8方法研究CTS对人眼脉络膜黑色素瘤(OCM-1)细胞的抑制作用。结果:CTS可以诱导人端粒DNA形成反平行G-四链体,对于OCM-1细胞具有较强的毒性,可以抑制其生长,而CTS对正常的人视网膜色素上皮(ARPE-19)细胞毒性极低,表明CTS可以作为以G-四链体为靶点的癌细胞潜在的靶向药物。结论:CTS可以促进G-四链体的生成,并对OCM-1细胞具有较强的抑制性,而对正常细胞影响微小。 Objective: To design and synthesize the potential antitumor drug, CTS (triethylenetetramine-starch). Its interactions with the human telomere DNA (d[G3(T2AG3)3 series]) and cytotoxicity to OCM-1 tumor cells are investigated. As a consequence, it provides a new strategy to develop targeted antitumor drugs. Methods: The triethylenetetramine reacted with the epichlorohydrin crosslinked-starch (CS) to produce the CTS. It was characterized by various methods. The circular diehroism (CD) spectra were used to clarify the interaction mechanism between the CTS and human telomere DNA. Its cytotoxity to OCM-1 cells was determined by CCK- 8 method. Results: The antiparallel G-quadruplex could be induced and stabilized by CTS. This may be the reason that CTS inhibited the growth of OCM-1 cells, and moreover it showed very low cytotoxicity to ARPE-19 human cells. Such observations indicated that CTS was a promising antitumor drug. Conclusion: The CTS can stabilize the G-quadruplex and has higher cytotoxicity to OCM-1 cells. It has insignificant effects on the growth of normal human cells.
出处 《温州医科大学学报》 CAS 2016年第1期19-23,共5页 Journal of Wenzhou Medical University
基金 国家自然科学基金资助项目(21405115) 浙江省医药卫生科研项目(2015KYB254) 温州市科技局科技计划项目(Y20120218) 温州医科大学附属眼视光医院项目(YNCX2014 08)
关键词 三乙烯四胺基淀粉 G-四链体 CD光谱 抗癌 triethylenetetramine-starch G-quadruplex CD spectra antitumor
  • 相关文献

参考文献15

  • 1BOCHMAN M L, PAESCHKE K, ZAKIAN V A. DNA sec- ondary structures: stability and function of G-quadruplex structures [J]. Nat Rev Genet. 2012, 13(11 ): 770-780.
  • 2CHOW T T; ZHAO Y, MAK S S, et al. Early and late steps in telomere overhang processing in normal human cells: the position of the final RNA primer drives telomere shortening [J]. Genes Dev, 2012, 26(11): 1167-1178.
  • 3D1NSHAW J P, ANH T P, VITALY K. Human telomere, on- cogenic promoter and 5"-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics[J]. Nucleic Acids Res, 2007, 35(22): 7429-7455.
  • 4LIU T, LIANG X, LI B, et al. Telomerase reverse transcrip- tase inhibiton stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celocoxib to exert anti-can- cer effects [J]. Br J Cancer, 2013, 108(11): 2272-2280.
  • 5MOCELLIN S, POOLEY K A, NITT D. Telomerase and the search for the end of cancer[J]. Trends Mol Med, 2013, 19(2): 125-133.
  • 6BIFFI G, TANNAHILL D, MCCAFFERTY J, et al. Quanti- tative visualization of DNA G-quadruplex structures in hu- man cells [J]. Nat Chem, 2013, 5(3): 182-186.
  • 7MELCHIORRE C, BOLOGNESI M L, M1NARINI A, et al. Polyamines in drug discovery: from the universal tem- plate approach to the multitarget-directed ligand design strategy[J]. J Med Chem, 2010, 53(16): 5906-5914.
  • 8LIU J, GUO L, YIN F, et al. Characterization and antitumor activity of triethylene tetramine, a novel telomerase inhibitor [J]. Biomed Pharmacother, 2008, 62(7): 480-485.
  • 9IGARASHI K, KASHIWAGI K. Modulation of cellular function by polyamines[J]. Int J Biochem Cell Biol, 2010, 42(1): 39-51.
  • 10WONG P E, TETLEY L, DUFES C, et al. Polyamine aza-cyclic compounds demonstrate anti-proliferative activi- ty in vitro but fail to control tumour growth in vivo[J]. J Pharm Sci, 2010, 99(11): 4642-4657.

二级参考文献16

  • 1Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children[J]. Arerugi, 1967, 16(3): 178- 222.
  • 2Li XH, Li XJ, Li H, et al. Epidemiological survey of Kawa?saki disease in Sichuan province of China[J]. J Trop Pediatr, 2008,54(2): 133-136.
  • 3Murchison EP, Hannon OJ. miRNAs on the move: miRNA biogenesis and the RNAi machinery[J]. Curr Opin Cell Bioi, 2004,16(3): 223-229.
  • 4Maragkakis M, Alexiou P, Papadopoulos OL, et al. Accurate microRNA target prediction correlates with protein repres?sion levels[J]. BMC Bioinforrnatics, 2009, 10: 295.
  • 5Shimizu C, Kim J, Stepanowsky P, et al. Differential expres?sion ofmiR-145 in children with Kawasaki disease[J]. PLoS One, 2013, 8(3): e58159.
  • 6Yun KW, Lee JY, Yun SW, et a1. Elevated serum level ofmi?croRNA (miRNA)-200c and miRNA-371-5p in children with Kawasaki disease[J]. Pediatr Cardiol, 2014, 35(5): 745- 752.
  • 7Rowley AH, Pink AJ, Reindel R, et a1. A study of cardiovas?cular miRNA biomarkers for Kawasaki disease[J]. Pediatr Infect Dis J, 2014, 33(12): 1296-1299.
  • 8Ni FF, Li CR, Li Q, et a1. Regulatory T cell microRNA ex?pression changes in children with acute Kawasaki disease[J]. Clin Exp Immunol, 2014, 178(2): 384-393.
  • 9Inoue Y, Kimura H, Kato M, et a1. Sera from patients with Kawasaki disease induce intercellular adhesion molecule-l but not Fas in human endothelial cells[J]. lnt Arch Allergy lmmunol, 2001,125(3): 250-255.
  • 10Terai M, Kohno Y, Namba M, et a1. Class II major histocom?patibility antigen expression on coronary arterial endothe- lium in a patient with Kawasaki disease[J]. Hum Pathol, 1990,21(2): 231-234.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部